Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ani Pharmaceuticals (ANIP) Preferred Dividend Payments (2021 - 2025)

Historic Preferred Dividend Payments for Ani Pharmaceuticals (ANIP) over the last 7 years, with Q3 2025 value amounting to $344000.0.

  • Ani Pharmaceuticals' Preferred Dividend Payments fell 1527.09% to $344000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 381.54%. This contributed to the annual value of $1.6 million for FY2024, which is 0.0% changed from last year.
  • Per Ani Pharmaceuticals' latest filing, its Preferred Dividend Payments stood at $344000.0 for Q3 2025, which was down 1527.09% from $407000.0 recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' Preferred Dividend Payments ranged from a high of $407000.0 in Q2 2022 and a low of $190000.0 during Q4 2021
  • Moreover, its 5-year median value for Preferred Dividend Payments was $406000.0 (2022), whereas its average is $388875.0.
  • As far as peak fluctuations go, Ani Pharmaceuticals' Preferred Dividend Payments surged by 11421.05% in 2022, and later crashed by 1527.09% in 2025.
  • Ani Pharmaceuticals' Preferred Dividend Payments (Quarter) stood at $190000.0 in 2021, then surged by 114.21% to $407000.0 in 2022, then fell by 0.25% to $406000.0 in 2023, then changed by 0.0% to $406000.0 in 2024, then fell by 15.27% to $344000.0 in 2025.
  • Its Preferred Dividend Payments stands at $344000.0 for Q3 2025, versus $407000.0 for Q2 2025 and $406000.0 for Q1 2025.